Agenus Inc. (AGEN)
Biotechnology · Healthcare · $111M
Intrinsic Value (Consensus)
$20.19
Current Price
$2.88
Margin of Safety
+300%
300% Below Intrinsic Value
Value: $20
Price: $3
Valuation Model Estimates
Current Price: $2.88
DCF (Discounted Cash Flow)
$14.87
Graham Number
Not applicable
—
Earnings Power Value
$12.35
Relative Value (P/E)
$33.36
Dividend Discount Model
Not applicable
—
Consensus Value
$20.19
Model Assumptions
Discount Rate
0.0%
Growth Rate
5.3%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
40
Profitability
10/25
Strength
8/25
Valuation
15/25
Growth
7/25
Key Financials
- EPS (TTM)
- $1.67
- EPS (Forward)
- $1.76
- Book Value
- —
- P/E Ratio
- —
- Forward P/E
- —
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 5.3%
- Dividend Yield
- 0.0%
- Beta
- 1.53
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
ATRAAtara Biotherapeutic...
$41.43+300%
NVAXNOVAVAX INC
$36.38+295.4%
Data last updated: 2026-06-26
Source: Yahoo Finance